CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer
Dr. Tse's Extensive Track Record in Oncology Early Clinical Development Will Strengthen CStone's Core Competence as a Clinical Development Engine and Solidify CStone's Position Among Leading Innovative Biopharma Companies in China
SUZHOU, China, Dec. 10... Biopharmaceuticals, Oncology, Personnel CStone Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news